Chaoju Eye Care Holdings Ltd. (HK:2219) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chaoju Eye Care Holdings Ltd., through its subsidiary Chaoju Medical Technology, has invested a total of RMB240 million in structured deposit products with the Bank of China (BOC), following previous investments in May and August 2024. These low-risk, principal-guaranteed structured deposits are expected to yield an annualized return between 1.3% and 3.15% and are linked to the EUR/USD exchange rate. The investments, funded by surplus cash, have been disclosed as per regulatory requirements due to their aggregated size.
For further insights into HK:2219 stock, check out TipRanks’ Stock Analysis page.